Should we rename low risk cancers?
BMJ
.
2019 Jan 23:364:k4699.
doi: 10.1136/bmj.k4699.
Authors
Laura J Esserman
1
,
Murali Varma
2
Affiliations
1
UCSF Carol Franc Buck Breast Care Center, San Francisco, CA, USA laura.esserman@ucsf.edu.
2
Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK laura.esserman@ucsf.edu.
PMID:
30674473
DOI:
10.1136/bmj.k4699
No abstract available
MeSH terms
Disease Progression
Female
Humans
Incidence
Male
Neoplasms / diagnosis*
Neoplasms / epidemiology*
Neoplasms / psychology
Recurrence
Risk*
Terminology as Topic